Minnetronix Medical Sharpens Image Quality for the First FDA-Cleared Wireless Surgical Camera

Lazurite taps Minnetronix optical expertise to raise the bar in wireless navigation

Wireless Surgical Camera: Minnetronix Medical announces it was selected by Lazurite, which develops innovative medical devices to set new operating room standards for efficiency and patient safety, as its development and manufacturing partner for the new ArthroFree™ Wireless Surgical Camera System.

ArthoFree is the first and only such camera system to receive FDA 510(k) market clearance.

Minnetronix was chosen by Lazurite for its experience in designing, developing, manufacturing, and commercializing complex optical systems. The team of optics experts at Minnetronix optimized the ArthroFree’s image signal processing chain – the signal path an image takes to travel through the system, from initial capture on an image sensor to on-screen display. The Minnetronix team was able to reduce latency and increase image quality, enabling physicians to see high-quality real-time video from the wireless device.

“We found a technical solution to overcome the assumption that a wireless device can’t
perform as well as a traditional wired system,” said Minnetronix vice president and
general manager Matt Adams. “The ability to move from wired to wireless with the
same, or even enhanced, clarity sets a new standard in the industry.”

Minnetronix also applied its design-for-manufacturability expertise to the project,
identifying several enhancements to make the device more efficient to manufacture,
reducing cost and assembly time.

The ArthroFree System is designed to be a modular system that is drop-in compatible with existing patient data consoles, surgical displays, and endoscopes used in minimally
invasive operating rooms.

“From end-to-end, Minnetronix provides the expertise needed to commercialize the
device,” said Eugene Malinskiy, chief executive officer and cofounder of Lazurite. “Our
goal was to be the first wireless surgical camera to receive FDA clearance. The quality of our system and the manufacturability of its design were a result of our partnership with Minnetronix and two major factors in achieving our goal.”

Minnetronix’s work with Lazurite is the most recent example of the growth of the
company’s optics business. In March, it announced its role in bringing Oculogica’s
concussion diagnostic device to market and launched a strategic partnership with the
optics research organization INO.

SourceLazurite
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version